Dr.RaviCardio said:Amycretin (AMY/GLP-1 dual agonist) emerging data relevant to the pharmacology: Phase 1 showed -13.1% body weight at only 12 weeks, the fastest…
Saving this. It is the first explanation that did not require me to already understand it. Printing the relevant bit and taking it with me.